1. Home
  2. |Insights
  3. |IG Report Whacks DCMA's Oversight of Contractors' Business Systems

IG Report Whacks DCMA's Oversight of Contractors' Business Systems

Client Alert | less than 1 min read | 10.13.15

On October 1, the DoD IG released a report entitled, "Evaluation of Defense Contract Management Agency Actions on Reported DoD Contractor Business System Deficiencies," asserting that DCMA contracting officers "repeatedly" failed to comply with DFARS requirements involving reported business system deficiencies. The report, which is similar to one issued on June 29 regarding DCMA's treatment of estimating system deficiencies (available here), focused its criticisms on DCMA, despite DCMA's comments noting that DCAA, rather than DCMA, is responsible for determining whether a "significant" business system deficiency exists.

 

Insights

Client Alert | 3 min read | 11.17.26

CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs

On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.  ...